Adenocarcinoma  >>  Tookad (padeliporfin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
NCT01573156 / 2011-003311-27: Vascular Targeted Photodynamic Therapy T1a Renal Tumours

Terminated
2a
5
Europe
Light activated WST11, Tookad Soluble
University of Oxford, Steba Biotech S.A.
Renal Cancer
05/14
06/15
NCT00975039 / 2009-011897-14: Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Terminated
2
8
Europe
WST11, WST11-mediated VTP
Steba Biotech S.A.
Cholangiocarcinoma
06/11
09/12

Download Options